[Federal Register Volume 85, Number 96 (Monday, May 18, 2020)]
[Notices]
[Pages 29741-29742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10601]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-610]


Bulk Manufacturer of Controlled Substances Application: SpecGx 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 17, 2025.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration (DEA), Attention: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 29, 2020, SpecGx LLC, 3600 North Second 
Street, Saint Louis, Missouri 63147-3457 applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substances:

------------------------------------------------------------------------
           Controlled substance                Drug code      Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.................            2010  I

[[Page 29742]]

 
Tetrahydrocannabinols.....................            7370  I
Codeine-N-oxide...........................            9053  I
Dihydromorphine...........................            9145  I
Difenoxin.................................            9168  I
Morphine-N-oxide..........................            9307  I
Normorphine...............................            9313  I
Norlevorphanol............................            9634  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-           9821  I
 yl)-N-phenylacetamide).
Butyryl Fentanyl..........................            9822  I
Fentanyl related-substances as defined in             9850  I
 21 CFR 1308.11(h).
Amphetamine...............................            1100  II
Methamphetamine...........................            1105  II
Lisdexamfetamine..........................            1205  II
Methylphenidate...........................            1724  II
Nabilone..................................            7379  II
4-Anilino-N-phenethyl-4-piperidine (ANPP).            8333  II
Codeine...................................            9050  II
Dihydrocodeine............................            9120  II
Oxycodone.................................            9143  II
Hydromorphone.............................            9150  II
Diphenoxylate.............................            9170  II
Ecgonine..................................            9180  II
Hydrocodone...............................            9193  II
Levorphanol...............................            9220  II
Meperidine................................            9230  II
Methadone.................................            9250  II
Methadone intermediate....................            9254  II
Dextropropoxyphene, bulk (non-dosage                  9273  II
 forms).
Morphine..................................            9300  II
Oripavine.................................            9330  II
Thebaine..................................            9333  II
Opium tincture............................            9630  II
Opium, powdered...........................            9639  II
Oxymorphone...............................            9652  II
Noroxymorphone............................            9668  II
Alfentanil................................            9737  II
Remifentanil..............................            9739  II
Sufentanil................................            9740  II
Tapentadol................................            9780  II
Fentanyl..................................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (APIs) for distribution to its customers. In reference to 
drug code 7370 (Tetrahydrocannabinols), the company plans to bulk 
manufacture this drug as synthetic. No other activities for this drug 
code is authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-10601 Filed 5-15-20; 8:45 am]
 BILLING CODE 4410-09-P